Fenoflox 50 mg/ml Solution for Injection for Cattle, Pigs, Dogs and Cats
Fenoflox 50 mg/ml Solution for Injection for Cattle, Pigs, Dogs and Cats
Authorised
- Enrofloxacin
Product identification
Medicine name:
Fenoflox 50 mg/ml Solution for Injection for Cattle, Pigs, Dogs and Cats
CHANENRO 50 MG/ML SOLUTION INJECTABLE POUR BOVINS, PORCINS, CHIENS ET CHATS
Active substance:
- Enrofloxacin
Target species:
-
Pig
-
Cattle
-
Dog
-
Cat
Route of administration:
-
Intramuscular use
-
Intravenous use
-
Subcutaneous use
Product details
Active substance and strength:
-
Enrofloxacin50.00milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Pig
-
Meat and offal13day
-
-
Intravenous use
- Cattle
-
Meat and offal5day
-
-
Subcutaneous use
- Cattle
-
Meat and offal12day
-
- Dog
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01MA90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Package description:
- Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap Container colour: Amber Container volume: 250 ml No. of containers in a carton: 20 x 250 ml
- Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap Container colour: Amber Container volume: 250 ml No. of containers in a carton: 15 x 250 ml
- Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap Container colour: Amber Container volume: 250 ml No. of containers in a carton: 12 x 250 ml
- Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap Container colour: Amber Container volume: 250 ml No. of containers in a carton: 10 x 250 ml
- Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap Container colour: Amber Container volume: 250 ml No. of containers in a carton: 5 x 250 ml
- Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap Container colour: Amber Container volume: 250 ml No. of containers in a carton: 1 x 250 ml
- Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap Container colour: Amber Container volume: 100 ml No. of containers in a carton: 20 x 100 ml
- Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap Container colour: Amber Container volume: 100 ml No. of containers in a carton: 15 x 100 ml
- Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap Container colour: Amber Container volume: 100 ml No. of containers in a carton: 12 x 100 ml
- Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap Container colour: Amber Container volume: 100 ml No. of containers in a carton: 10 x 100 ml
- Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap Container colour: Amber Container volume: 100 ml No. of containers in a carton: 5 x 100 ml
- Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap Container colour: Amber Container volume: 100 ml No. of containers in a carton: 1 x 100 ml
Additional information
Entitlement type:
-
Marketing Authorisation
Marketing authorisation holder:
- Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Labiana Life Sciences S.A.
- Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
- National Veterinary Medicines Agency
Authorisation number:
- FR/V/7839791 4/2010
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0223/001
Concerned member states:
-
Austria
-
Belgium
-
Cyprus
-
Czechia
-
Finland
-
France
-
Germany
-
Hungary
-
Italy
-
Luxembourg
-
Poland
-
Portugal
-
Slovakia
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
How useful was this page?: